Asarfi Hospital Limited has reported strong financial performance for its recent quarter, along with outlining ambitious expansion plans. The company's Board of Directors approved the results at a recent meeting.

Financial Results

Asarfi Hospital achieved consolidated revenue of ₹80.60 crores, marking a substantial 50% year-on-year growth. The company's Profit After Tax (PAT) rose by 70% to ₹7.32 crores. These results demonstrate robust financial health and operational efficiency, driven by doubled inpatient volumes and the successful launch of the Cancer Institute.

Vision 2027 and Expansion Plans

Asarfi Hospital has outlined its Vision 2027, setting ambitious targets for growth and expansion:

• Increase bed capacity to 500
• Achieve revenue of ₹200.00 crores
• Reach EBITDA margin of 25-27%

The company plans to achieve these goals through:

1. Expansion into Bihar and Eastern Uttar Pradesh
2. Introduction of advanced service lines, including bone marrow transplants
3. Vertical integration with education services

Current Operations

The company currently operates two hospitals in Dhanbad with a combined capacity of 330 beds.

Market Implications

The expansion plans and introduction of advanced services suggest that Asarfi Hospital is positioning itself for growth in the coming years. The focus on expanding into new geographical areas and introducing specialized services could potentially enhance the hospital's market position and patient base.

Corporate Structure

Asarfi Hospital Limited operates primarily in the hospital segment. The company has a subsidiary named Asarfi Educational Foundation, which aligns with its plans for vertical integration with education services.

The company's shares are listed on the BSE SME platform.

Asarfi Hospital Limited , a leading healthcare provider in Eastern India, has reported robust financial results for the second quarter and half-year ended September 30, 2025, alongside securing significant funding for expansion.

Financial Highlights

The company's standalone financial results show impressive growth:

The consolidated results mirror this strong performance, with revenue reaching ₹80.57 crore for H1 FY2026, marking a 50% year-on-year increase.

Operational Performance

Asarfi Hospital has shown significant improvement in key operational metrics:

Super-Specialty Hospital Unit

• ARPOB (Average Revenue Per Occupied Bed) increased to ₹19,839 in H1 FY2026 from ₹16,925 in H1 FY2025
• Bed occupancy rate improved to 64% from 59% year-on-year

Cancer Hospital Unit

• ARPOB saw a substantial rise to ₹41,401 in H1 FY2026 from ₹16,602 in H1 FY2025
• Occupancy rate increased to 44% from 26% year-on-year

Expansion and Funding

During the quarter, Asarfi Hospital secured important funding for its growth initiatives:

1. A term loan of ₹4.68 crore from State Bank of India for purchasing and installing a new Cath Lab at their Dhanbad facility
2. A ₹2.00 crore fund-based Bank Guarantee limit for corporate and PSU empanelments

These financial arrangements are expected to enhance the hospital's capabilities and market position.

Strategic Developments

The company has entered into a partnership with Gleneagles Chennai to establish Jharkhand's first-ever Multi-Organ Transplant Unit. This collaboration aims to provide world-class transplant services for heart, lungs, kidney, liver, and bone marrow under one roof, potentially transforming Jharkhand from a "Medical Desert" into a "Medical Destination."

Future Outlook

Asarfi Hospital's Vision 2027 includes ambitious targets:

• Expanding to 500 beds
• Achieving ₹200 crore in revenues
• Maintaining EBITDA margins of 25-27%
• Targeting PAT margins of 13-15%

The company plans to increase bed capacity in its super-specialty hospital from 265 to 350 and in the cancer hospital from 65 to 150 within the next two years.

With its strong financial performance, strategic expansions, and partnerships, Asarfi Hospital Limited appears well-positioned for continued growth in the healthcare sector of Eastern India.